AstraZeneca strikes deal with Oxford Biomedica to make COVID-19 vaccine candidate

Thursday, May 28, 2020 - 18:30 in Mathematics & Economics

AstraZeneca and Oxford Biomedica announced a deal Thursday to work together to manufacture a potential vaccine for COVID-19 that is set to enter advanced trials in June.

Read the whole article on UPI

More from UPI

Latest Science Newsletter

Get the latest and most popular science news articles of the week in your Inbox! It's free!

Check out our next project, Biology.Net